The Latest Breaking News from Food and Drug Administration

The decision that overturned the FDA’s approval of mifepristone is on hold as the nation’s high court considers the case

A decision could come Friday — and could effectively override the Food and Drug Administration's decision-making.

The Food and Drug Administration says it found a host of problems at an Indian manufacturing plant recently linked to contaminated eyedrops

Since a group of pro-life plaintiffs first challenged the Food and Drug Administration’s approval of mifepristone, one of the two drugs used in chemical or medication abortions, the reporting on the case has been predictable.

Nature, last month (paywall): The US Food and Drug Administration (FDA) will soon require [based on new federal legislation] researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants…. The diversity requirement arrives in the wake of a 2022 report from…

Patients’ access to lifesaving medicine is under threat because an anti-abortion rights organization sued in federal district court to overrule the Food and Drug Administration’s approval of mifepristone, which has been used to terminate early pregnancies for almost a quarter century in the U.S. If the judge, appointed by the…

Dairy producers for years have called for the FDA to crack down on plant-based drinks and other products that they say masquerade as animal-based foods and cloud the real meaning of “milk.”

The Food and Drug Administration has new tools to hold drug companies accountable for promises they make about medications. But the agency has yet to show its hand in using this new power.

The jabs could be ready as soon as this summer, one expert tells Fortune.